- Home
- ELVN vs UDMY Comparison
ELVN vs UDMY Comparison
Compare ELVN & UDMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVN
- UDMY
- Stock Information
- Founded
- ELVN 2016
- UDMY 2009
- Country
- ELVN United States
- UDMY United States
- Employees
- ELVN N/A
- UDMY 1246
- Industry
- ELVN Biotechnology: Pharmaceutical Preparations
- UDMY Other Consumer Services
- Sector
- ELVN Health Care
- UDMY Real Estate
- Exchange
- ELVN Nasdaq
- UDMY Nasdaq
- Market Cap
- ELVN 1.2B
- UDMY 1.1B
- IPO Year
- ELVN 2020
- UDMY 2021
- Fundamental
- Price
- ELVN $19.32
- UDMY $6.99
- Analyst Decision
- ELVN Strong Buy
- UDMY Buy
- Analyst Count
- ELVN 5
- UDMY 10
- Target Price
- ELVN $41.20
- UDMY $9.78
- AVG Volume (30 Days)
- ELVN 410.5K
- UDMY 1.3M
- Earning Date
- ELVN 08-12-2025
- UDMY 07-30-2025
- Dividend Yield
- ELVN N/A
- UDMY N/A
- EPS Growth
- ELVN N/A
- UDMY N/A
- EPS
- ELVN N/A
- UDMY N/A
- Revenue
- ELVN N/A
- UDMY $790,019,000.00
- Revenue This Year
- ELVN N/A
- UDMY $1.87
- Revenue Next Year
- ELVN N/A
- UDMY $4.15
- P/E Ratio
- ELVN N/A
- UDMY N/A
- Revenue Growth
- ELVN N/A
- UDMY 5.43
- 52 Week Low
- ELVN $13.30
- UDMY $5.68
- 52 Week High
- ELVN $30.03
- UDMY $10.61
- Technical
- Relative Strength Index (RSI)
- ELVN 40.65
- UDMY 48.33
- Support Level
- ELVN $21.25
- UDMY $6.80
- Resistance Level
- ELVN $22.83
- UDMY $7.90
- Average True Range (ATR)
- ELVN 1.42
- UDMY 0.29
- MACD
- ELVN -0.35
- UDMY 0.03
- Stochastic Oscillator
- ELVN 5.60
- UDMY 35.46
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About UDMY Udemy Inc.
Udemy Inc operates a marketplace platform at the center of a vibrant knowledge network. The company operates under two operating and reportable segments Consumer and Enterprise, out of which the Enterprise segment derives the maximum revenue. Geographically, the company derives maximum revenue from North America. The company leverages data, technology, and insights for effective learning experiences. It helps individuals and organizations to possess effective skill acquisition and development with flexibility.